Can I cancel
Mochi Health names its partner pharmacies in the portal and lets patients select one, which is rare in the compounded GLP-1 category
If your BMI is 27 or higher, you may still be an ideal candidate if you manage at least one weight-related medical condition, such as high blood pressure, high cholesterol, or obstructive sleep apnea
Friedman School of Nutrition Science and Policy at Tufts University, recently served as lead chair and author of a clinical advisory titled Nutritional Priorities to Support GLP-1 Therapy for Obesity, published across four peer-reviewed journals and issued by four leading organizations in lifestyle medicine, obesity medicine, and nutritionthe American College of Lifestyle Medicine (ACLM), the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and The Obesity Society (TOS)
In fields like oncology, this approach is already standard
FDA determined the national tirzepatide injection shortage was resolved and in 2026 reiterated that compounders must satisfy the individualized requirements and copy restrictions in sections 503A and 503B